Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Asset disposition
Inv. presentation
Acq. announced
|
|
OPKO HEALTH, INC. (OPK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2022 |
SC 13D
| Zerhouni Elias A. reports a 5.8% stake in OPKO HEALTH, INC. |
| 06/29/2022 |
SC 13D
| Nabel Gary J. reports a 5.8% stake in OPKO HEALTH, INC. |
| 05/09/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/29/2019 |
SC 13D
| Opko Health, Inc. reports a 7% stake in Xenetic Biosciences, Inc. |
| 06/12/2019 |
SC 13D
| Opko Health, Inc. reports a 31.1% stake in BioCardia, Inc. |
| 06/12/2019 |
SC 13D
| Opko Health, Inc. reports a 35.3% stake in Non-Invasive Monitoring Systems, Inc. |
| 06/12/2019 |
SC 13D
| Opko Health, Inc. reports a 5% stake in Neovasc, Inc. |
| 06/12/2019 |
SC 13D
| Opko Health, Inc. reports a 6.8% stake in VBI Vaccines, Inc. |
| 05/09/2019 |
SC 13D
| Opko Health, Inc. reports a 5.9% stake in Chromadex Corporation |
| 05/09/2019 |
SC 13D
| Opko Health, Inc. reports a 0.3% stake in PHIO PHARMACEUTICALS CORP. |
| 05/09/2019 |
SC 13D
| Opko Health, Inc. reports a 3.6% stake in ELOXX PHARMACEUTICALS, INC. |
| 05/09/2019 |
SC 13D
| Opko Health, Inc. reports a 0% stake in SORRENTO THERAPEUTICS, INC. |
| 05/09/2019 |
SC 13D
| Opko Health, Inc. reports a 11.6% stake in Cocrystal Pharma, Inc. |
| 08/04/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/31/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 03/22/2013 |
SC 13D
| RXi Pharmaceuticals Corp reports a 20.9% stake in RXi Pharmaceuticals Corporation |
| 09/22/2009 |
SC 13D
| Sorrento Therapeutics, Inc. has filed a Schedule 13D for QUIKBYTE SOFTWARE, INC. |
|
|